USANA Health Sciences Net Profit Margin 2006-2018 | USNA

USANA Health Sciences net profit margin from 2006 to 2018. Net profit margin can be defined as net Income as a portion of total sales revenue.
USANA Health Sciences Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2018-12-31 $1.19B $0.13B 10.60%
2018-09-30 $1.16B $0.09B 7.57%
2018-06-30 $1.13B $0.08B 7.18%
2018-03-31 $1.08B $0.07B 6.46%
2017-12-31 $1.05B $0.06B 5.92%
2017-09-30 $1.03B $0.09B 8.76%
2017-06-30 $1.02B $0.10B 9.42%
2017-03-31 $1.02B $0.10B 9.70%
2016-12-31 $1.01B $0.10B 9.94%
2016-09-30 $0.99B $0.10B 10.34%
2016-06-30 $0.97B $0.10B 10.16%
2016-03-31 $0.94B $0.10B 10.33%
2015-12-31 $0.92B $0.10B 10.35%
2015-09-30 $0.91B $0.09B 10.08%
2015-06-30 $0.87B $0.09B 9.75%
2015-03-31 $0.83B $0.08B 9.55%
2014-12-31 $0.79B $0.08B 9.62%
2014-09-30 $0.75B $0.08B 10.03%
2014-06-30 $0.73B $0.07B 10.00%
2014-03-31 $0.73B $0.08B 10.67%
2013-12-31 $0.72B $0.08B 11.00%
2013-09-30 $0.70B $0.08B 10.98%
2013-06-30 $0.69B $0.08B 11.13%
2013-03-31 $0.66B $0.07B 10.54%
2012-12-31 $0.65B $0.07B 10.17%
2012-09-30 $0.63B $0.06B 9.74%
2012-06-30 $0.61B $0.06B 9.26%
2012-03-31 $0.59B $0.05B 8.94%
2011-12-31 $0.58B $0.05B 8.58%
2011-09-30 $0.58B $0.05B 8.52%
2011-06-30 $0.57B $0.05B 8.83%
2011-03-31 $0.54B $0.05B 8.66%
2010-12-31 $0.52B $0.05B 8.88%
2010-09-30 $0.50B $0.04B 8.85%
2010-06-30 $0.47B $0.04B 8.25%
2010-03-31 $0.46B $0.04B 8.06%
2009-12-31 $0.44B $0.03B 7.78%
2009-09-30 $0.43B $0.03B 6.50%
2009-06-30 $0.43B $0.03B 6.56%
2009-03-31 $0.42B $0.03B 6.84%
2008-12-31 $0.43B $0.03B 6.76%
2008-09-30 $0.43B $0.04B 8.43%
2008-06-30 $0.43B $0.04B 9.15%
2008-03-31 $0.43B $0.04B 9.41%
2007-12-31 $0.42B $0.05B 10.61%
2007-09-30 $0.41B $0.04B 10.73%
2007-06-30 $0.40B $0.04B 10.86%
2007-03-31 $0.38B $0.04B 11.11%
2006-12-31 $0.37B $0.04B 10.96%
2006-09-30 $0.34B $0.04B 11.63%
2006-06-30 $0.33B $0.04B 11.98%
2006-03-31 $0.33B $0.04B 12.27%
2005-12-31 $0.32B $0.04B 12.38%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.922B $1.189B
USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $48.866B 32.47
Takeda Pharmaceutical (TAK) Japan $28.763B 10.64
Grifols (GRFS) Spain $13.022B 15.92
Ionis Pharmaceuticals (IONS) United States $10.380B 32.19
Sage Therapeutics (SAGE) United States $7.864B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.405B 10.60
Neurocrine Biosciences (NBIX) United States $7.366B 474.77
Catalent (CTLT) United States $6.473B 27.10
Nektar Therapeutics (NKTR) United States $5.505B 8.78
Tilray (TLRY) United States $4.865B 0.00
United Therapeutics (UTHR) United States $4.561B 7.76
Taro Pharmaceutical Industries (TARO) Israel $4.165B 13.41
FibroGen (FGEN) United States $4.101B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.841B 0.00
Portola Pharmaceuticals (PTLA) United States $2.408B 0.00
PTC Therapeutics (PTCT) United States $2.130B 0.00
Heron Therapeutics (HRTX) United States $1.884B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.856B 0.00
Xencor (XNCR) United States $1.836B 0.00
Aerie Pharmaceuticals (AERI) United States $1.814B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.797B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.734B 21.60
Madrigal Pharmaceuticals (MDGL) United States $1.685B 0.00
Endo (ENDP) Ireland $1.656B 2.55
Pacira Pharmaceuticals (PCRX) United States $1.617B 139.82
Zogenix (ZGNX) United States $1.586B 0.00
Corcept Therapeutics (CORT) United States $1.408B 20.45
Tricida (TCDA) United States $1.385B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.321B 0.00
Esperion Therapeutics (ESPR) United States $1.171B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.079B 0.00
TherapeuticsMD (TXMD) United States $1.008B 0.00
Radius Health (RDUS) United States $0.995B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.898B 0.00
Akebia Therapeutics (AKBA) United States $0.781B 0.00
CannTrust Holdings (CTST) Canada $0.767B 0.00
ChemoCentryx (CCXI) United States $0.738B 0.00
ArQule (ARQL) United States $0.713B 0.00
Dermira (DERM) United States $0.612B 0.00
Odonate Therapeutics (ODT) United States $0.604B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.595B 0.00
Forty Seven (FTSV) United States $0.583B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.578B 0.00
GlycoMimetics (GLYC) United States $0.562B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.555B 0.00
Collegium Pharmaceutical (COLL) United States $0.495B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.472B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.465B 24.03
TCR2 THERAPTCS (TCRR) United States $0.450B 0.00
KalVista Pharmaceuticals (KALV) United States $0.448B 0.00
Translate Bio (TBIO) United States $0.441B 0.00
Siga Technologies (SIGA) United States $0.437B 0.00
OptiNose (OPTN) United States $0.418B 0.00
Flexion Therapeutics (FLXN) United States $0.408B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.393B 0.00
Aptorum Group (APM) China $0.389B 0.00
Mast Therapeutics (SVRA) United States $0.383B 0.00
ImmunoGen (IMGN) United States $0.375B 0.00
CASI Pharmaceuticals (CASI) United States $0.318B 0.00
Karyopharm Therapeutics (KPTI) United States $0.303B 0.00
Minerva Neurosciences (NERV) United States $0.287B 0.00
Harpoon Therapy (HARP) United States $0.286B 0.00
Lannett Co Inc (LCI) United States $0.283B 2.63
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.280B 10.38
AcelRx Pharmaceuticals (ACRX) United States $0.276B 0.00
Xeris Pharmaceuticals (XERS) United States $0.259B 0.00
Aclaris Therapeutics (ACRS) United States $0.258B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.255B 0.00
Calithera Biosciences (CALA) United States $0.246B 0.00
Dova Pharmaceuticals (DOVA) United States $0.241B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.237B 0.00
Molecular Templates (MTEM) United States $0.236B 0.00
Concert Pharmaceuticals (CNCE) United States $0.227B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.226B 0.00
Aldeyra Therapeutics (ALDX) United States $0.225B 0.00
Ardelyx (ARDX) United States $0.222B 0.00
MEI Pharma (MEIP) United States $0.218B 0.00
Galectin Therapeutics (GALT) United States $0.210B 0.00
Rafael Holdings (RFL) United States $0.206B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.204B 0.00
Affimed (AFMD) Germany $0.203B 0.00
Opexa Therapeutics (ACER) United States $0.200B 0.00
Jounce Therapeutics (JNCE) United States $0.190B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.185B 0.00
Recro Pharma (REPH) United States $0.184B 0.00
Nature's Sunshine Products (NATR) United States $0.183B 190.00
Majesco Entertainment (PTE) United States $0.183B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.179B 0.00
AgeX Therapeutics (AGE) United States $0.178B 0.00
Neon Therapeutics (NTGN) United States $0.176B 0.00
ElectroCore (ECOR) United States $0.176B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.174B 0.00
Redhill Biopharma (RDHL) Israel $0.170B 0.00
Aratana Therapeutics (PETX) United States $0.169B 0.00
Ocular Therapeutix (OCUL) United States $0.165B 0.00
IMV INC (IMV) Canada $0.165B 0.00
Tyme Technologies (TYME) United States $0.163B 0.00
Aquestive Therapeutics (AQST) United States $0.154B 0.00
MediWound (MDWD) Israel $0.143B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.142B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.136B 0.00
China SXT Pharmaceuticals (SXTC) China $0.120B 0.00
ProNAi Therapeutics (SRRA) Canada $0.118B 0.00
Neos Therapeutics (NEOS) United States $0.115B 0.00
Iterum Therapeutics (ITRM) Ireland $0.114B 0.00
Cardiome Pharma (CORV) Canada $0.105B 0.00
Champions Oncology (CSBR) United States $0.097B 0.00
Natural Alternatives (NAII) United States $0.096B 9.37
Oasmia Pharmaceutical AB (OASM) Sweden $0.095B 0.00
Nivalis Therapeutics (ALPN) United States $0.094B 0.00
DURECT (DRRX) United States $0.092B 0.00
Zafgen (ZFGN) United States $0.091B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.091B 0.00
Adherex Technologies (FENC) United States $0.090B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.089B 0.00
Infinity Pharmaceuticals (INFI) United States $0.089B 0.00
Bio Blast Pharma (ENLV) Israel $0.089B 0.00
SCYNEXIS (SCYX) United States $0.085B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.085B 0.00
Otonomy (OTIC) United States $0.082B 0.00
Genocea Biosciences (GNCA) United States $0.078B 0.00
Avenue Therapeutics (ATXI) United States $0.075B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.064B 0.00
Capnia (SLNO) United States $0.064B 0.00
India Globalization Capital (IGC) United States $0.061B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.061B 0.00
CTI BioPharma (CTIC) United States $0.059B 0.00
Forward Pharma (FWP) Denmark $0.056B 0.00
Melinta Therapeutics (MLNT) United States $0.052B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.048B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.047B 0.00
Bio-Path Holdings (BPTH) United States $0.045B 0.00
KemPharm (KMPH) United States $0.045B 0.00
Lipocine (LPCN) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.042B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.041B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.039B 0.00
Heat Biologics (HTBX) United States $0.039B 0.00
ContraFect (CFRX) United States $0.038B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
HANCOCK JAFFE (HJLI) United States $0.031B 0.00
IsoRay (ISR) United States $0.028B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.028B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.028B 3.62
Achieve Life Sciences (ACHV) United States $0.027B 0.00
Shineco (TYHT) China $0.027B 4.58
PharmAthene (ALT) United States $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
Onconova Therapeutics (ONTX) United States $0.023B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
NOVAN INC (NOVN) United States $0.022B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Pain Therapeutics (SAVA) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.013B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 3.76
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.010B 0.00
Can-Fite Biopharma (CANF) Israel $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
Achaogen (AKAO) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00